Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1 Preformulation in Drug Discovery
  • Track 1-2 Preformulation in Drug Development
  • Track 1-3 Drug Formulation Considerations
  • Track 1-4 Major Challenges in Drug Development
  • Track 1-5 Physiological Drug Environment
  • Track 1-6 Freeze Drying
  • Track 1-7 Hot Melt Extrusion

  • Track 2-1 Pharmacokinetic Parameters
  • Track 2-2 Pharmacodynamic Parameters
  • Track 2-3 Absorption of Drugs
  • Track 2-4 Distribution of Drugs
  • Track 2-5 Biotransformation/Metabolism
  • Track 2-6 Excretion of Drugs
  • Track 2-7 Pharmacodynamics

  • Track 3-1 Drug Targeting strategies
  • Track 3-2 Factors influencing Drug Targeting
  • Track 3-3 Advances in Drug Targeting components
  • Track 3-4 Recent Approaches to Drug Targeting
  • Track 3-5 Rational Drug Design
  • Track 3-6 Computer Aided Drug Design

  • Track 4-1 Oral Drug Delivery
  • Track 4-2 Buccal Drug Delivery
  • Track 4-3 Nasal Drug Delivery
  • Track 4-4 Ophthalmic Drug Delivery
  • Track 4-5 Topical Drug Delivery
  • Track 4-6 Pulmonary Drug Delivery
  • Track 4-7 Parenteral Drug Delivery
  • Track 4-8 Rectal Drug Delivery
  • Track 4-9 Vaginal Drug Delivery
  • Track 4-10Geriatric Drug Delivery
  • Track 4-11Paediatric Drug Delivery

  • Track 5-1Liposomal Drug Delivery Systems
  • Track 5-2Microemulsions and Nanoemulsions
  • Track 5-3Solid Lipid Nano and Microparticles
  • Track 5-4Organic Nanotubes: Promising Vehicles for Drug Delivery
  • Track 5-5Dendrimers
  • Track 5-6Micelles
  • Track 5-7Cyclodextrins
  • Track 5-8Polymers
  • Track 5-9Nanogels
  • Track 5-10Metal Nanoparticles and Quantum Dots

  • Track 6-1Cosmetics
  • Track 6-2Controlled Drug Delivery
  • Track 6-3Transdermal Drug Delivery
  • Track 6-4Dermal Drug Delivery
  • Track 6-5Antimicrobial nanoemulsions
  • Track 6-6Cancer therapy
  • Track 6-7Treatment of other diseases
  • Track 6-8Oral delivery of poorly soluble drugs

  • Track 7-1Pharmaceutical Nanotechnology based Systems
  • Track 7-2Characterization of Pharmaceutical Nanotools
  • Track 7-3Engineering of Pharmaceutical Nanosystems
  • Track 7-4Applications of Pharmaceutical Nanotools
  • Track 7-5Challenges to Pharmaceutical Nanotechnology
  • Track 7-6Future Prospects of Pharmaceutical Nanotechnology

  • Track 8-1Targeted Drug Delivery
  • Track 8-2Brain Delivery
  • Track 8-3Mucosal Drug Delivery
  • Track 8-4Skin Drug Delivery
  • Track 8-5Pulmonary Drug Delivery
  • Track 8-6Cancer Delivery
  • Track 8-7Insulin Delivery
  • Track 8-8Self-Emulsifying Drug Delivery Systems (SEDDS)
  • Track 8-92D and 3D Printing In Drug Delivery
  • Track 8-10BioMEMS
  • Track 8-11Blood Brain Barrier Delivery
  • Track 8-12Antibody Targeted-Drug Conjugates
  • Track 8-13Nucleic Acid Drug Delivery Systems
  • Track 8-14Gene Delivery

  • Track 9-1Cells and Proteins
  • Track 9-2Proteins and Surfaces
  • Track 9-3Ceramics and Metals
  • Track 9-4Polymers
  • Track 9-5Wound Healing
  • Track 9-6Translational Sciences
  • Track 9-7Biomaterials Processing & Devices
  • Track 9-83D Printing Technologies
  • Track 9-9Biomaterials & Therapeutics
  • Track 9-10Musculoskeletal
  • Track 9-11Nanomaterials & Nanotechnologies
  • Track 9-12Tissue Regeneration

  • Track 10-1Cancer vaccines
  • Track 10-2Influenza vaccines/virus
  • Track 10-3Novel vaccines
  • Track 10-4Clinical trials
  • Track 10-5Human vaccines
  • Track 10-6HIV/AIDS vaccines
  • Track 10-7HPV vaccines
  • Track 10-8Therapeutic vaccination for auto immune diseases
  • Track 10-9New vaccines
  • Track 10-10Veterinary vaccines
  • Track 10-11Computed Tomographic Scanning (CT Scanning)
  • Track 10-12Magnetic Resonance Imaging

  • Track 11-1Biomedical Instrumentation Measurements
  • Track 11-2Measurement of Blood Flow and Cardiac Output
  • Track 11-3Instrumentation for Psychophysiological Measurements
  • Track 11-4Instrumentation for the Experimental Analysis of Behaviour
  • Track 11-5Respiratory Therapy Equipment
  • Track 11-6Pacemakers and Defibrillators
  • Track 11-7Quality by Design (QbD)
  • Track 11-8Instrumentation for the Medical Use of Radioisotopes
  • Track 11-9Ophthalmic and ENT Instruments
  • Track 11-10Ultrasonography
  • Track 11-11Positron-Emission Tomographic (PET) Scanning

  • Track 12-1Peptide Vector for Biologics Brain Delivery
  • Track 12-2Protein Formulation & Aggregation
  • Track 12-3Protein therapeutics
  • Track 12-4Polymers for delivery of proteins
  • Track 12-5Peptide therapeutics
  • Track 12-6Peptide therapeutics
  • Track 12-7Cell-penetrating and cell-targeting